Skip to content

Evaluating the Efficacy of Ayurvedic Formulation INS 00l in Treating Insomnia

To determine the efficacy of an Ayurvedic formulation INS00l in treating Insomnia disorder A pilot feasibility study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073278
Enrollment
30
Registered
2024-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F519- Sleep disorder not due to a substance or known physiological condition, unspecified

Interventions

None listed

Sponsors

Sri Sri Institute for advanced research SSIAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male and Female participant above 18 to 60 years of age and willing to give written inform Consent. 2.Perceived total sleep time of more than 6 hours per night 3.Patient with history of self-reported primary insomnia or with diagnosis of primary insomnia (as defined by the Diagnostic and Statistical Manual for Mental Disorders-IV.

Exclusion criteria

Exclusion criteria: 1.Female who are pregnant, breast feeding or not willing to use adequate contraception during the course of the study. 2.Patient with psychiatric illness or concomitant disorder or any other condition that could potentially disturb or have impact on sleep. 3.Patients using tobacco products or caffeinated beverages during night awakenings. 4.Patients on any medication for insomnia. 5.Patients using any sedative hypnotic drugs including benzodiazepines, non-benzodiazepine synthetic drugs, herbal and OTC products. 6.Patients working in night shifts within 5 days of screening or intended to do so during the course of the study. 7.Patients with history of alcohol abuse or drugs abuse. 8.Patients who were using any other medication that are known to influence sleep but could not be withdrawn. 9.Patients who are participated in another investigational drug had been used within three months prior to screening in this study. 10.Patients who could not be relied upon to comply with the study procedures.

Design outcomes

Primary

MeasureTime frame
Improvement in Sleep duration and Sleep quality.Timepoint: Day0,Day15,Day30.

Secondary

MeasureTime frame
To evaluate the sleep quality of individuals under Ayurveda medication.Timepoint: Day0,Day15,Day30.

Countries

India

Contacts

Public ContactDr Yogeshwar Chippa

Sri Sri Institue of Advanced Research

yogeshwar.chippa@ssiar.org9975264201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026